Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Phase 3 Real Estate Partners and Bain Capital Real Estate have snagged a $484 million loan to refinance a 561,000-square-foot life sciences campus in Brisbane. The San Diego-based developer and ...

A joint venture between Phase 3 Real Estate Partners and Bain Capital Real Estate has sealed a $484 million loan to refinance a life sciences campus near San Francisco. “With attractive long-term ...

By Sneha S K and Sriparna Roy (Reuters) -Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it does not already own for $25.75 ...

Race for TPG-backed Sai Life Sciences: Bain Capital likely lead suitor at $800 mn valuation In 2018, TPG Capital invested around $135 million in Sai Life Sciences and the private equity firm ...

US-based Bain Capital has increased its takeover bid for Australian wealth manager Insignia Financial to A$2.87bn ($1.76bn). The offer matches the indicative non-binding buyout offer made last ...

Jan 13 (Reuters) - Shares of Australia's Insignia Financial (IFL.AX), opens new tab hit a more than three-year high on Monday as a bidding war escalated, with private equity firm Bain Capital ...